EPS Holdings Inc (4282)

EPS Holdings, Inc., through its subsidiaries, provides outsourced solutions to customers in the healthcare industry. It provides contract research organization (CRO) services and management of CRO segment activities; site management organization services; contract MR services, DI, and other call center services related BPO services, as well as medical device support services; contract sales solutions, including recruitment, training, and development of MRs (permanent, contract staffing, and temp to-perm), as well as medical communications programs and training; and promotion and BPO services for healthcare companies. The company also engages in clinical research related business; provision of IT services for pharmaceutical and medical settings; the import and export of products for non-clinical research, and provision of distribution services; research and development, manufacture, and sale of pharmaceuticals and medical devices; and provision of human studies (functionality and safety evaluations), basic research and animal studies, food composition analysis, research on functional substances, and other research and analysis services, as well as consulting in support of functional food development and other activities. In addition, it engages in trading, investment, and other businesses; shared services; rental and sale of advanced medical and other devices; and sale of clinical trial and other types of life and non-life insurance. The company serves pharmaceutical companies, medical device manufacturers, pharmaceutical development ventures, medical institutions, and universities and research institution in Japan and Asia. EPS Holdings, Inc. was founded in 1991 and is based in Tokyo, Japan. As of July 8, 2021, EPS Holdings, Inc. operates as a subsidiary of Y&G Limited.